Metraipolis › archive › dc_a79fe6538bf6

Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study — Europe PMC PMID:41661445

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41661445
DOI
10.1007/s40618-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-06T00:51:01.346Z
SHA-256 of the archived text
02517bd07148b5e5a2a2faf99c62e11374a88bf3bfa7bc892ac01b413003ea59
Stable URL of this page
https://metraipolis.com/documento/dc_a79fe6538bf6

How to cite

Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study — Europe PMC PMID:41661445 — Europe PMC (en), https://europepmc.org/article/MED/41661445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a79fe6538bf6 (Metraipolis archive dc_a79fe6538bf6, sha256 02517bd07148b5e5a2a2faf99c62e11374a88bf3bfa7bc892ac01b413003ea59)
BibTeX
@misc{dca79fe6538bf6,
  title = {Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study — Europe PMC PMID:41661445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41661445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a79fe6538bf6; sha256 02517bd07148b5e5a2a2faf99c62e11374a88bf3bfa7bc892ac01b413003ea59},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41661445. Agents can read the archived copy with the MCP tool read_document.